216 related articles for article (PubMed ID: 11037549)
1. Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria.
Komaki R; Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Weisenburger TH; Kaiser LR; Leibel SA; Choi NC
Radiology; 2000 Jun; 215 Suppl():1319-30. PubMed ID: 11037549
[No Abstract] [Full Text] [Related]
2. Non-aggressive, non-surgical treatment of inoperable non-small cell lung cancer (NSCLC). American College of Radiology. ACR Appropriateness Criteria.
Graham MV; Byhardt RW; Sause WT; Curran WJ; Fuller D; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA
Radiology; 2000 Jun; 215 Suppl():1347-62. PubMed ID: 11037551
[No Abstract] [Full Text] [Related]
3. Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
Weisenburger TH; Graham MV; Sause WT; Byhardt RW; Curran WJ; Fuller D; Ko B; Komaki R; Kaiser LR; Leibel SA
Radiology; 2000 Jun; 215 Suppl():1295-318. PubMed ID: 11037548
[No Abstract] [Full Text] [Related]
4. Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA; Brown RC
Radiology; 2000 Jun; 215 Suppl():1363-72. PubMed ID: 11037552
[No Abstract] [Full Text] [Related]
5. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
Koukourakis M
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
[No Abstract] [Full Text] [Related]
6. ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung.
Gopal RS; Dubey S; Rosenzweig KE; Chang JY; Decker R; Gewanter RM; Kong FM; Lally BE; Langer CJ; Lee HK; Movsas B
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):969-74. PubMed ID: 20813465
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer.
Neville A
Clin Evid; 2002 Jun; (7):1369-83. PubMed ID: 12230752
[No Abstract] [Full Text] [Related]
8. Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.
Socinski MA; Detterbeck FC; Rivera MP; Egan TM; Halle J; Rosenman J
N C Med J; 1996; 57(5):281-6. PubMed ID: 8854691
[No Abstract] [Full Text] [Related]
9. [What is effective in non-small cell lung carcinoma?].
Pneumologie; 1996 Jun; 50(6):X. PubMed ID: 8766369
[No Abstract] [Full Text] [Related]
10. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
Tanaka F; Wada H
Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
[TBL] [Abstract][Full Text] [Related]
11. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
Chen Y; Guo W; Lu Y; Zou B
Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684
[TBL] [Abstract][Full Text] [Related]
12. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
Baumann M
Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
[No Abstract] [Full Text] [Related]
13. [A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer versus conventionally fractionated 60 Gy: results of a randomized equivalence study].
Zagamé L; Noël G; Mazeron JJ
Cancer Radiother; 2001 Apr; 5(2):199. PubMed ID: 11355587
[No Abstract] [Full Text] [Related]
14. Chemotherapy in stage III non-small cell lung cancer.
Eberhardt WE; Hepp R
Eur J Cancer; 2009 Sep; 45 Suppl 1():126-36. PubMed ID: 19775611
[No Abstract] [Full Text] [Related]
15. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
Mornex F
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
[No Abstract] [Full Text] [Related]
16. [Radiation treatment of lung cancer].
Hayakawa K
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1211-4. PubMed ID: 17847583
[No Abstract] [Full Text] [Related]
17. Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapy.
Bogart JA; Aronowitz JN
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5004s-5010s. PubMed ID: 16000604
[TBL] [Abstract][Full Text] [Related]
18. Is surgery for T4 non-small-cell lung cancer worthwhile?
Pramesh CS; Mistry RC; Deshpande RK; Sharma S
Ann Thorac Surg; 2004 Aug; 78(2):753; author reply 753-4. PubMed ID: 15276574
[No Abstract] [Full Text] [Related]
19. [Place of radiotherapy in treatment of non small cell lung cancer].
Chmielewska E; Jodkiewicz Z
Pneumonol Alergol Pol; 2002; 70(1-2):110-6. PubMed ID: 12148171
[No Abstract] [Full Text] [Related]
20. NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
Wurstbauer K; Deutschmann H; Kopp P; Kranzinger M; Merz F; Nairz O; Studnicka M; Sedlmayer F
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():38-40. PubMed ID: 18167008
[No Abstract] [Full Text] [Related]
[Next] [New Search]
